US 12,691,091 · Application 17/613,719 · Granted Jul 28, 2026
US 12,691,091
Compositions comprising cetylated fatty acids for use in the treatment of gastric mucosa, diabetes and high blood glucose levels
Estimated expiration
September 17, 2042
16y 13d remaining
- Could not fetch continuity data for application PCTIB2020055031: Resource not found (404)
Earliest effective filing
May 27, 2020
+ 20 years
May 27, 2040
PTA +843d
Sep 17, 2042
No TD
—
Final
Sep 17, 2042
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- November 23, 2021
- Earliest effective filing
- May 27, 2020
- Issue date
- July 28, 2026
- PTA
- +843 days
- Base expiry (before PTA)
- May 27, 2040
May 27, 2020 + 20 years = May 27, 2040 + 843 PTA days = September 17, 2042
- National stage entry of application PCTIB2020055031, filed May 27, 2020
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/613,719 · US 12,691,091
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,691,091: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12691091Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.